Cannabiz awaits the vaccine

The arrival of two FDA-approved corona vaccines suggests the pandemic could be under control, or at least more under control, within months. But what does it mean for the cannabis industry, where work has never stopped and so much rhetoric within the space presents weed as an alternative to conventional medicine?

WeedWeek talked to Laura Bianchi, a partner with Arizona firm Bianchi & Brandt, about how her cannabis clients think about vaccination.

This interview has been edited for length and . . .